Mirum Pharmaceuticals, Inc.
MIRMNASDAQHealthcareBiotechnology
As of Oct 22, 2026 close
- Market cap
- $5.27B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $63.23$130.00
- Volume (live)
- -
- Avg. volume (3M)
- 830.03K
Mirum Pharmaceuticals (MIRM) Stock Price & Financial Analysis
Mirum Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $82.58 - $84.86 |
|---|---|
| 52-Week High | $130.00 |
| 52-Week Low | $63.23 |
| Open | $83.26 |
| Volume (last close) | 420.91K |
| Average Volume (3M) | 830.03K |
| Revenue (TTM) | 618.07M |
|---|---|
| Net Income (TTM) | -860.21M |
| Free Cash Flow (TTM) | -458.17M |
| EPS (TTM) | −$15.00 |
| Profit Margin | -139.18% |
| Operating Margin | -17.42% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 5.27B |
|---|---|
| Shares Outstanding | 63.37M |
| Price to Sales (P/S) | 8.52 |
| Price to Book (P/B) | -505.32 |
| EV/EBITDA | -7.33 |
| 50-Day MA | $92.41 |
|---|---|
| 200-Day MA | $98.57 |
| 1-Year Change | +19.72% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Mirum Pharmaceuticals at a Glance
As of the Oct 22, 2026 close, Mirum Pharmaceuticals (MIRM) has a market capitalization of $5.27B. The stock trades at 8.5× sales. Over the trailing twelve months it lost $860.21M on revenue of $618.07M and burned $458.17M of free cash flow. Revenue grew 44.0% year over year.
As of its latest reported balance sheet, it holds $330.73M in cash and securities against $760.54M of debt, a net debt position of $429.82M.
Mirum Pharmaceuticals does not currently pay a dividend.
The share price is up 19.7% over the past year. At $83.10 (the Oct 22, 2026 close) it sits within its 52-week range of $63.23 to $130.00, below its 200-day moving average of $98.57.
Based on 13 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $154.00, 85.3% above the Oct 22, 2026 close.
Frequently Asked Questions About Mirum Pharmaceuticals
What is the current stock price for MIRM?
As of the Oct 22, 2026 close, MIRM stock trades at $83.10. The 52-week range is $63.23–$130.00, with a day range of $82.58–$84.86.
What is the P/E ratio for MIRM?
The P/E ratio (Price-to-Earnings) for MIRM is shown in the Key Statistics section. This valuation metric helps compare Mirum Pharmaceuticals, Inc. to industry peers.
Does MIRM pay dividends?
Mirum Pharmaceuticals does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for MIRM?
Based on ratings from 13 professional analysts over the last 90 days, the consensus for MIRM is Buy. The average 12-month price target is $154.00, a 85.3% upside from the Oct 22, 2026 close of $83.10.
What is the market cap of MIRM?
As of the Oct 22, 2026 close, Mirum Pharmaceuticals's market capitalization is $5.27B, classifying it as a mid-cap company. Mirum Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.